Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract ...

A collaborative team of researchers from the Donald Danforth Plant Science Center, the University of Florida, Gainesville and ...

Driven AI with World-Class Ocean Science to Solve Earth-Scale Problems In a Time That Matters AOS was founded to push the limits of what’s possible, combining our teams accelerates that ...

Researchers develop an AI-based platform that integrates reaction data with catalyst performance for the design of new ...

Employer-sponsored insurance continues to cover the majority of Americans, but employers are facing mounting cost pressures ...

Gilead Sciences has found a shiny new package for one of its cancer assets, inking a research pact worth up to $300 million ...

TangGene names former GSK SVP Catherine Sohn as Senior Strategic Advisor, strengthening leadership as it advances a first-in-class in-vivo CD8⁺ Treg therapy. TangGene’s in-vivo CD8⁺ Treg approach has ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Employer-sponsored insurance continues to cover the majority of Americans, but employers are facing mounting cost pressures ...